A-100 Selected pro-and anti-inflammatory cytokine serum concentrations in different clinical forms of multiple sclerosis
T. Yang,H. Xing,S. Dai,C. Yan,N. Wang,W. Zhang,A. Tran,A.,Beshiri,A. Soh,Y. Zheng,F. Shen,B. V. Shenoy,R. F. Tutrone,L. I. Karsh,W. J. Harmon,D. L. Broyles,T. E. Roddy,L. R. Lofaro,M. A. Reynolds
2017-01-01
Abstract:Background: Multiple sclerosis (MS) is an immune-mediated central nervous system disease characterized by inflammation, demyelination and axonal degeneration. The pathology of MS suggests an autoimmune cause involving cellular and humoral components of the immune system. Active MS lesions are characterized by T-cell and macrophage infiltration and the presence of immune mediators, including adhesion molecules, chemokines, and cytokines. Cytokines are proven mediators of immunological process in MS. The aim of this study was to delineate the serum cytokine profile in patients with MS and the controls and to determine in different clinical forms of MS. Methods: This study involved 62 consecutive MS patients--28 patients with progressive MS and 34 patients with relapsing-remitting MS (RRMS). The control group consisted of 18, age and sex matched, non-immunological, neurological patients. The patients were evaluated using the Expanded Disability Status Scale (EDSS) and magnetic resonance imaging (MRI) with gadolinium. Serum samples for cytokine measurements were collected on admission. Plasma levels of proinflammatory T-helper (TH)1 (interferon (IFN)-γ) cytokines, peripheral monokines (IL-1beta, IL-6, TNF-alpha) and anti-inflammatory or down-regulatory TH2 cytokines (IL-4, IL-10) were determined by an enzyme-linked immunosorbent assay (ELISA) method. Results: All patients with MS had significantly higher cytokine (IFN-γ, IL-1β, IL-6, TNF-α, IL-4, IL-10) concentrations compared with controls (p < 0.001). Increased IL1beta, IFN-γ (p=0.032 and 0.041, respectively) and decreased IL-4, IL-10 (p=0.038 and 0.02, respectively) levels were found in progressive MS compared with RRMS. Patients with progressive MS with disease progression presented higher IL-1beta, TNF-alpha, IFN-γ and IL-10 levels than those without disease progression (p < 0.05). There was a significant inverse correlation between IL-10 levels and EDSS score in patients with progressive MS (R = 0.43, p < 0.05). Conclusion: Profiling cytokines in multiple sclerosis may help to identify mechanisms involved in the pathogenesis of the disease, and, potentially, lead to new therapies directed at cytokines or their receptors. The level of IL-10 can serve as an additional diagnostic criterion for assessing the disability in patients with progressive MS.